Semaglutide for the treatment of antipsychotic-associated weight gain in patients not responding to metformin - a case series

• Main Authors: Femin Prasad (Author), Riddhita De (Author), Vittal Korann (Author), Araba F. Chintoh (Author), Gary Remington (Author), Bjørn H. Ebdrup (Author), Dan Siskind (Author), Filip Krag Knop (Author), Tina Vilsbøll (Author), Anders Fink-Jensen (Author), Margaret K. Hahn (Author), Sri Mahavir Agarwal (Author)
• Format: Book
• Published: SAGE Publishing, 2023-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Metformin is the currently accepted first-line treatment for antipsychotic-associated weight gain (AAWG). However, not all patients benefit from metformin. Glucagon-like peptide-1 receptor agonists (GLP1-RA) have shown promise in the management of obesity in the general population, with preliminary...